‘A game-changer’: How Spartan retooled its patented rapid DNA test to tackle COVID-19
Ottawa biotech firm predicts revenues will top $200 million this year – and only rise from there.
‘A game-changer’: How Spartan retooled its patented rapid DNA test to tackle COVID-19
Ottawa biotech firm predicts revenues will top $200 million this year – and only rise from there.
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored
Didn’t we just do this? More changes coming to the Ontario Construction Act
Do I need an engineer for my construction project?
EVENT ALERT: Mayor's Breakfast with Ontario Finance Minister on Wednesday, Dec. 4 @ City Hall